Manufacturing the drug substance for Zoetis’ first-in-class mAb osteoarthritis drug - Syngene ...
Whatif

Manufacturing the drug substance for Zoetis’ first-in-class mAb osteoarthritis drug - Syngene ...

1920 × 1280 px December 11, 2024 Zeus

Manufacturing the drug substance for Zoetis’ first-in-class mAb osteoarthritis drug - Syngene ... is a high-quality image in the Whatif collection, available at 1920 × 1280 pixels resolution — ideal for both digital and print use.

Discover what improves osteoarthritis effectively. Explore proven relief methods, including joint exercises, anti-inflammatory diets, and physical therapy.

Image Details

TitleManufacturing the drug substance for Zoetis’ first-in-class mAb osteoarthritis drug - Syngene ...
Dimensions1920 × 1280 px
CategoryWhatif
PublishedDecember 11, 2024
AuthorZeus
Downloads964
Views1,509

Frequently Asked Questions

This image has a resolution of 1920 × 1280 pixels. It is suitable for high-quality printing, digital presentations, and web use without losing clarity.
This image is part of the Whatif collection. You can browse more images in this category to find similar content.
Click the Download button above the image to save it directly to your device. The image is provided in its original resolution of 1920 × 1280 px.
Yes! Scroll down to the More Images section below to explore related Whatif images. You can also visit the full article for more context and a complete image gallery.

Read full article: What Improves Osteoarthritis